Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dexcom (DXCM) Operating Margin (2016 - 2026)

Dexcom has reported Operating Margin over the past 17 years, most recently at 21.42% for Q1 2026.

  • Quarterly Operating Margin rose 851.0% to 21.42% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 21.45% through Mar 2026, up 620.0% year-over-year, with the annual reading at 19.56% for FY2025, 468.0% up from the prior year.
  • Operating Margin was 21.42% for Q1 2026 at Dexcom, down from 25.64% in the prior quarter.
  • Over five years, Operating Margin peaked at 25.64% in Q4 2025 and troughed at 6.37% in Q1 2023.
  • The 5-year median for Operating Margin is 15.73% (2024), against an average of 16.04%.
  • The largest YoY upside for Operating Margin was 1530bps in 2022 against a maximum downside of -591bps in 2022.
  • A 5-year view of Operating Margin shows it stood at 15.38% in 2022, then surged by 36bps to 20.97% in 2023, then dropped by -19bps to 16.96% in 2024, then surged by 51bps to 25.64% in 2025, then fell by -16bps to 21.42% in 2026.
  • Per Business Quant, the three most recent readings for DXCM's Operating Margin are 21.42% (Q1 2026), 25.64% (Q4 2025), and 20.05% (Q3 2025).